Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ASB
ASB logo

ASB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Associated Banc-Corp (ASB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
28.200
1 Day change
-0.55%
52 Week Range
29.520
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Associated Banc-Corp (ASB) does not present a compelling buy opportunity for a beginner investor with a long-term horizon at this time. While the technical indicators show some bullish trends, the financial performance is concerning with significant YoY declines in net income and EPS. Analysts have upgraded the stock recently, but the price target increases are modest, and there are no strong catalysts to suggest immediate upside potential. The lack of significant insider or hedge fund activity, as well as no recent congress trading data, further supports a cautious approach.

Technical Analysis

The technical indicators show a bullish trend with MACD above 0 and positively contracting, RSI in a neutral zone at 64.757, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 27.775), which could limit short-term upside.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
8

Positive Catalysts

  • Recent analyst upgrades to 'Overweight' with higher price targets, citing strong growth trajectory and potential benefits from higher interest rates. Appointment of a new market president to strengthen regional presence.

Neutral/Negative Catalysts

  • Lack of significant insider or hedge fund activity. No recent congress trading data.

Financial Performance

In Q4 2025, revenue increased significantly by 533.42% YoY, but net income dropped by -181.63%, and EPS fell by -176.92%. Gross margin remains at 0%. The financials indicate growth in revenue but poor profitability metrics.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent upgrades from Barclays and Stephens to 'Overweight' with price targets of $33 and $29, respectively. Truist lowered its price target to $27, citing higher cost of equity. Analysts are generally optimistic but with mixed views on valuation.

Wall Street analysts forecast ASB stock price to rise
7 Analyst Rating
Wall Street analysts forecast ASB stock price to rise
0 Buy
7 Hold
0 Sell
Hold
Current: 28.360
sliders
Low
29
Averages
30.33
High
33
Current: 28.360
sliders
Low
29
Averages
30.33
High
33
Barclays
Jared Shaw
Equal Weight
to
Overweight
upgrade
$30 -> $33
AI Analysis
2026-04-07
Reason
Barclays
Jared Shaw
Price Target
$30 -> $33
AI Analysis
2026-04-07
upgrade
Equal Weight
to
Overweight
Reason
Barclays analyst Jared Shaw upgraded Associated Banc-Corp to Overweight from Equal Weight with a price target of $33, up from $30, ahead of the Q1 report. The firm cites the bank's "strong growth trajectory and continued turnaround" for the upgrade. Asset sensitive banks will benefit from the move higher in rates, the analyst tells investors in a research note.
Stephens
Equal Weight -> Overweight
upgrade
$29
2026-03-27
Reason
Stephens
Price Target
$29
2026-03-27
upgrade
Equal Weight -> Overweight
Reason
Stephens upgraded Associated Banc-Corp to Overweight from Equal Weight with a $29 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ASB
Unlock Now

People Also Watch